Trial in progress: Phase 1a/b study of PF-07284890 (brain-penetrant BRAF inhibitor) with/without binimetinib in patients with BRAF V600-mutant solid tumors Meeting Abstract
| Authors: | Subbiah, V.; Gutierrez, M.; Anders, C. K.; Ansstas, G.; Owonikoko, T. K.; Monga, V.; Forsyth, P. A. J.; Dagogo-Jack, I.; Chandra, S.; Tsai, K. K.; Diamond, E. L.; McKean, M.; Buchbinder, E. I.; Nepert, D.; Ingram, K.; Oliver, C.; Reddy, M.; Maharry, K.; Xing, Y. |
| Abstract Title: | Trial in progress: Phase 1a/b study of PF-07284890 (brain-penetrant BRAF inhibitor) with/without binimetinib in patients with BRAF V600-mutant solid tumors |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120306231 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.TPS3152 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS3152 -- Source: Wos |
